MA40902A
Therapeutic hpv16 vaccines
Abstract
The invention provides nucleic acid constructs and designer polypeptides that can be used as therapeutic vaccines against hpv16.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
61 members in 33 offices
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 14191660 | European Patent Office (EPO) | A | |
| 14191660 | European Patent Office (EPO) | A | |
| 15791556 | European Patent Office (EPO) | A | |
| 15791556 | European Patent Office (EPO) | A | |
| 2015075516 | European Patent Office (EPO) | W | |
| 2015075516 | European Patent Office (EPO) | W | |
| 14191660 | – | – | – |
| EP20140191660 | – | – | – |
| EP20150791556 | – | – | – |
| WO2015EP75516 | – | – | – |
Members61
| Document | Office | Kind | |
|---|---|---|---|
| US2016122396A1 | United States of America | A1 | |
| CA2965562A1 | Canada | A1 | |
| WO2016071306A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201617450A | Taiwan Province of China | A | |
| AR102527A1 | Argentina | A1 | |
| AU2015341926A1 | Australia | A1 | |
| SG11201702997YA | Singapore | A | |
| IL251895A0 | Israel | A0 | |
| IL251895D0 | Israel | D0 | |
| US9701721B2 | United States of America | B2 | |
| KR20170083562A | Republic of Korea | A | |
| CO2017004838A2 | Colombia | A2 | |
| MX2017005788A | Mexico | A | |
| CN107075521A | China | A | |
| EP3215187A1 | European Patent Office (EPO) | A1 | |
| MA40902AThis record | Morocco | A | |
| EA201790976A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2017281747A1 | United States of America | A1 | |
| JP2017534286A | Japan | A | |
| CL2017001089A1 | Chile | A1 | |
| JP6325751B2 | Japan | B2 | |
| EP3215187B1 | European Patent Office (EPO) | B1 | |
| US10071151B2 | United States of America | B2 | |
| AU2015341926B2 | Australia | B2 | |
| JP2018148890A | Japan | A | |
| PT3215187T | Portugal | T | |
| US2018344841A1 | United States of America | A1 | |
| DK3215187T3 | Denmark | T3 | |
| BR112017009177A2 | Brazil | A2 | |
| LT3215187T | Lithuania | T | |
| MA40902B1 | Morocco | B1 | |
| EP3421046A1 | European Patent Office (EPO) | A1 | |
| HRP20181895T1 | Croatia | T1 | |
| AU2018282463A1 | Australia | A1 | |
| ES2697903T3 | Spain | T3 | |
| MD3215187T2 | Republic of Moldova | T2 | |
| RS58080B1 | Serbia | B1 | |
| SI3215187T1 | Slovenia | T1 | |
| HUE040440T2 | Hungary | T2 | |
| PL3215187T3 | Poland | T3 | |
| SA517381457A | Saudi Arabia | A | |
| MA46378A | Morocco | A | |
| IL251895A | Israel | A | |
| IL251895B | Israel | B | |
| JP6606571B2 | Japan | B2 | |
| ZA201703055B | South Africa | B | |
| US10555996B2 | United States of America | B2 | |
| TWI694147B | Taiwan Province of China | B | |
| US2020164057A1 | United States of America | A1 | |
| CY1121377T1 | Cyprus | T1 | |
| EA035461B1 | Eurasian Patent Organization (EAPO) | B1 | |
| AU2018282463B2 | Australia | B2 | |
| TW202043476A | Taiwan Province of China | A | |
| MY181175A | Malaysia | A | |
| SA517381457B1 | Saudi Arabia | B1 | |
| SA7690B1 | Saudi Arabia | B1 | |
| CN107075521B | China | B | |
| TWI731654B | Taiwan Province of China | B | |
| US11040096B2 | United States of America | B2 | |
| NZ730802A | New Zealand | A | |
| CA2965562C | Canada | C |
Numbers
- Publication
- 040902
- Publication, DOCDB
- 40902
- Publication, EPODOC
- MA40902
- Application
- 40902
- Application, DOCDB
- 40902
- Application, EPODOC
- MA20150040902
Titles2
- French
- VACCINS HPV16 THÉRAPEUTIQUES
- English
- THERAPEUTIC HPV16 VACCINES
Classification
- CPC, 20
- A61K39/12
- C07K14/005
- C12N15/86
- A61K2039/53
- A61K2039/585
- C12N2710/10043
- C12N2710/20034
- C12N2710/20022
- C12N2710/20071
- C12N2800/107
- A61K39/00
- A61P11/04
- A61P13/00
- A61P15/08
- A61P31/20
- A61P35/00
- A61P37/04
- C07K14/025
- C12N7/00
- C12N2710/10041
- IPC, 4
- A61K39 00
- A61K39 12
- C07K14 005
- C07K14 025